A postmarketing evaluation of the frequency of use and safety of live attenuated influenza vaccine use in nonrecommended children younger than 5 years

This publication has 16 references indexed in Scilit:

• Safety and efficacy of live attenuated influenza vaccine in children 2–7 years of age
  Vaccine, 2008
• Shedding of live vaccine virus, comparative safety, and influenza-specific antibody responses after administration of live attenuated and inactivated trivalent influenza vaccines to HIV-infected children
  Vaccine, 2008
• Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma–Summary Report 2007
  Journal of Allergy and Clinical Immunology, 2007
• Hospitalizations with Primary versus Secondary Discharge Diagnoses of Asthma: Implications for Pediatric Asthma Surveillance
  The Journal of Pediatrics, 2007
• Prednisolone reduces recurrent wheezing after a first wheezing episode associated with rhinovirus infection or eczema
  Journal of Allergy and Clinical Immunology, 2007
• Live Attenuated versus Inactivated Influenza Vaccine in Infants and Young Children
  New England Journal of Medicine, 2007
• Comparison of the Efficacy and Safety of Live Attenuated Cold-Adapted Influenza Vaccine, Trivalent, With Trivalent Inactivated Influenza Virus Vaccine in Children and Adolescents With Asthma
  The Pediatric Infectious Disease Journal, 2006
• Clinical and economic impact of influenza vaccination on healthy children aged 2–5 years
  Vaccine, 2006
• Beclomethasone dipropionate and salbutamol by metered dose inhaler in infants and small children with recurrent wheezing
  Pediatric Pulmonology, 2002
• Comparison of the Safety, Vaccine Virus Shedding, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A and B, Live Cold‐Adapted, Administered to Human Immunodeficiency Virus (HIV)–Infected and Non–HIV‐Infected Adults
  The Journal of Infectious Diseases, 2000